Clinical stage antiviral therapeutics company.
Monitor Ebola Supplemental Appropriations, H.R.83, "Making consolidated appropriations for the fiscal year ending September 30, 2015, and for other purposes." Monitor Ebola Supplemental Appropriations, H.R.83, "Making consolidated appropriations for the fiscal year ending September 30, 2015, and for other purposes." Monitor Ebola Supplemental Appropriations, H.R.83, "Making consolidated appropriations for the fiscal year ending September 30, 2015, and for other purposes."
BUD - Budget/Appropriations MED - Medical/Disease Research/Clinical Labs HCR - Health Issues
135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
MS. REBECCA HALKIAS
317 C Street, NE, Washington, DC, 20002, US
REBECCA HALKIAS REBECCA HALKIAS REBECCA HALKIAS